Plain-English translation of NCT04190849 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that brings together children with non-alcoholic fatty liver disease (NAFLD) from hospitals across Europe. Researchers will track your health over time through regular appointments and tests to understand how this condition develops in children, what causes it to worsen or improve, and how to help kids with fatty liver disease in the future.
Fatty liver disease in children is becoming more common, but doctors still don't fully understand why some children develop it or how to predict which ones will have serious complications. This study aims to fill those gaps by following many children over years, helping doctors develop better treatments and care plans.
You likely qualify if…
You likely don't qualify if…
You will be part of a registry that follows your health over several years through periodic visits to your hospital. At these visits, your doctors will perform routine blood tests, imaging scans, and clinical assessments to monitor your liver health. You may also be asked to provide tissue samples (such as a small liver biopsy) if recommended by your doctor, and your medical information will be shared securely with the European research network to help advance our understanding of fatty liver disease in children.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Netherlands
United Kingdom